Drugs Affecting Blood and Blood Formation Practice Questions

Q: Desferrioxamine is a drug used for:

Thalassemia. **Explanation:** **Desferrioxamine** is a potent **iron-chelating agent** used primarily to treat chronic iron overload. **Why Thalassemia is correct:** Patients with **Thalassemia Major** require lifelong, regular blood transfusions to manage severe anemia. Each unit of transfused blood contains approximately 200–250 mg of iron. Since the human body lacks an active physiological mechanism to excrete excess iron, it deposits in vital organs (heart, liver, endocrine glands), leading to **secondary hemochromatosis**. Desferrioxamine binds to ferric iron ($Fe^{3+}$) to form **ferrioxamine**, a water-soluble complex excreted by the kidneys, thereby preventing organ damage. **Why other options are incorrect:** * **Kala-azar:** Treated with Sodium Stibogluconate, Amphotericin B, or Miltefosine. * **Pernicious Anaemia:** Caused by Vitamin B12 deficiency due to lack of intrinsic factor; treated with parenteral Cyanocobalamin or Methylcobalamin. * **Pain control:** Managed with NSAIDs, Opioids, or adjuvant analgesics, not chelating agents. **High-Yield Clinical Pearls for NEET-PG:** * **Route of Administration:** Desferrioxamine is poorly absorbed orally; it is administered via slow subcutaneous or intravenous infusion. * **Oral Alternatives:** **Deferasirox** (once-daily oral drug) and **Deferiprone** are preferred for better patient compliance. * **Acute Toxicity:** It is also the drug of choice for **acute iron poisoning** (often seen in children). * **Side Effects:** Rapid IV injection can cause histamine release and hypotension. Long-term use may lead to visual and auditory neurotoxicity.

Q: Heparin is the commonly used anticoagulant in cardiac surgery. Which of the following statements about heparin is FALSE?

It is the weakest acid found in living beings.. ### Explanation **1. Why Option A is the Correct (False) Statement:** Heparin is actually the **strongest organic acid** found in the human body. It is a highly sulfated glycosaminoglycan with a high density of negative charges. This strong electronegativity is essential for its binding to antithrombin III and various proteins. Therefore, stating it is the "weakest acid" is factually incorrect. **2. Analysis of Incorrect Options (True Statements):** * **Option B:** Most commercial heparin is "Unfractionated Heparin" (UFH), primarily sourced from **porcine (pig) intestinal mucosa** or bovine (cow) lung. * **Option C:** Heparin acts indirectly. It binds to **Antithrombin III (AT-III)**, inducing a conformational change that accelerates the inactivation of clotting factors, primarily **Thrombin (IIa) and Factor Xa**, by 1,000 to 4,000 times. * **Option D:** Heparin-Induced Thrombocytopenia (HIT) is a serious immune-mediated adverse effect caused by IgG antibodies against the **Heparin-Platelet Factor 4 (PF4) complex**, leading to platelet activation and paradoxical thrombosis. **3. NEET-PG High-Yield Clinical Pearls:** * **Monitoring:** UFH is monitored using **aPTT** (intrinsic pathway). LMWH does not require routine monitoring but can be checked using **Anti-Factor Xa levels**. * **Antidote:** **Protamine sulfate** (a strong base) neutralizes heparin (a strong acid) via chemical antagonism. * **Drug of Choice:** Heparin is the anticoagulant of choice during **pregnancy** because its high molecular weight prevents it from crossing the placenta (unlike Warfarin, which is teratogenic). * **Cardiac Surgery:** Heparin is preferred in cardiopulmonary bypass due to its rapid onset and easy reversibility.

Q: A 90-year-old woman with a fractured neck of femur is receiving low-molecular-weight heparin (LMWH). Which of the following statements regarding LMWH is true?

Its anticoagulant effect is by binding to antithrombin III.. ### Explanation **1. Why the Correct Answer is Right:** Low-molecular-weight heparin (LMWH), like Enoxaparin or Dalteparin, exerts its anticoagulant effect by binding to **Antithrombin III (AT-III)**. This binding induces a conformational change in AT-III, which accelerates the inactivation of **Factor Xa**. Unlike Unfractionated Heparin (UFH), LMWH has a shorter polysaccharide chain, making it highly selective for Factor Xa inhibition with minimal effect on Thrombin (Factor IIa). **2. Why the Incorrect Options are Wrong:** * **Option A:** LMWH typically has a molecular weight ranging from **2,000 to 8,000 Daltons** (average ~4,500–5,000). Standard UFH is much larger (5,000–30,000 Daltons). * **Option C:** LMWH has a longer half-life and more predictable pharmacokinetics than UFH. It is typically administered **once or twice daily** subcutaneously, not three times. * **Option D:** LMWH has **higher and more consistent bioavailability** (~90%) compared to UFH (~20-30%) because it binds less to plasma proteins and endothelial cells. **3. NEET-PG High-Yield Pearls:** * **Monitoring:** Routine monitoring (aPTT) is **not required** for LMWH due to its predictable response. If needed (e.g., in pregnancy or renal failure), **Anti-Xa levels** are measured. * **Renal Clearance:** LMWH is primarily excreted by the kidneys; it is **contraindicated/used with caution in chronic kidney disease** (UFH is preferred here). * **HIT:** The risk of Heparin-Induced Thrombocytopenia (HIT) is significantly **lower** with LMWH than with UFH. * **Antidote:** Protamine sulfate only **partially neutralizes** LMWH (approx. 60%), whereas it completely reverses UFH.

Q: Megaloblastic anemia is caused by all of the following EXCEPT:

Aspirin. Megaloblastic anemia is characterized by impaired DNA synthesis, leading to the formation of large, immature red blood cell precursors. This is most commonly due to a deficiency or interference in the metabolism of Vitamin B12 or Folic acid [1, 2, 3]. **Why Aspirin is the Correct Answer:** **Aspirin** is a non-steroidal anti-inflammatory drug (NSAID) that inhibits cyclooxygenase (COX) enzymes. While chronic aspirin use can lead to **iron deficiency anemia** due to occult gastrointestinal bleeding, it does not interfere with DNA synthesis or folate/B12 metabolism. Therefore, it does not cause megaloblastic anemia. **Why the other options are incorrect:** * **Primidone:** This is an antiepileptic (metabolized to phenobarbital) that causes megaloblastic anemia by interfering with intestinal folate absorption and increasing its catabolism. * **Methotrexate:** A potent dihydrofolate reductase (DHFR) inhibitor. It prevents the conversion of dihydrofolate to tetrahydrofolate, directly halting DNA synthesis. * **Nitrous oxide:** Known as "laughing gas," it oxidizes the cobalt atom of Vitamin B12, rendering the enzyme methionine synthase inactive. This leads to a functional B12 deficiency. **High-Yield Clinical Pearls for NEET-PG:** * **Drugs causing Folate deficiency:** Phenytoin, Primidone, Phenobarbital, Methotrexate, Trimethoprim, and Pyrimethamine. * **Drugs causing B12 deficiency:** Metformin (decreases absorption in the terminal ileum), Proton Pump Inhibitors (PPIs), and Nitrous oxide. * **Zidovudine (AZT):** A common cause of macrocytosis/megaloblastic changes in HIV patients. * **Rescue Therapy:** Leucovorin (folinic acid) is used to "rescue" bone marrow from Methotrexate toxicity.

Q: Which of the following is a recombinant form of GM-CSF?

Sargramostim. ### Explanation The correct answer is **Sargramostim**. **1. Why Sargramostim is correct:** Sargramostim is a recombinant form of **Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)**. It is produced using yeast (*Saccharomyces cerevisiae*) expression systems. It works by stimulating the proliferation and differentiation of hematopoietic progenitor cells into neutrophils, monocytes/macrophages, and eosinophils. Clinically, it is used to accelerate myeloid recovery following chemotherapy, bone marrow transplantation, or in cases of mobilization of peripheral blood progenitor cells. **2. Analysis of Incorrect Options:** * **Filgrastim:** This is a recombinant form of **G-CSF** (Granulocyte Colony-Stimulating Factor). Unlike GM-CSF, it specifically stimulates the production of neutrophils only. It is more commonly used in clinical practice for chemotherapy-induced neutropenia. * **Aldesleukin:** This is a recombinant form of **Interleukin-2 (IL-2)**. It promotes the proliferation of T-cells and Natural Killer (NK) cells and is primarily used in the treatment of metastatic renal cell carcinoma and melanoma. * **Interleukin-11 (Oprelvekin):** This is a recombinant cytokine used to stimulate **megakaryocytopoiesis**, leading to increased platelet production. It is used to prevent severe thrombocytopenia following chemotherapy. **3. NEET-PG High-Yield Pearls:** * **Mnemonic:** Sar**gram**ostim = **Gran**ulocyte + **M**acrophage (GM-CSF). **Fil**grastim = Neutro**phil** (G-CSF). * **Side Effects:** Sargramostim can cause a "first-dose reaction" (hypotension, tachycardia, flushing) and pleural/pericardial effusions, which are less common with Filgrastim. * **Source:** Filgrastim is produced in *E. coli*, whereas Sargramostim is produced in yeast.

Q: Which of the following fibrinolytic agents can be given as a single weight-based intravenous bolus over 10 seconds?

Tenecteplase (TNK). **Explanation:** The correct answer is **Tenecteplase (TNK)**. The primary pharmacological goal in thrombolysis is to achieve rapid reperfusion with minimal bleeding complications. Tenecteplase is a genetically engineered mutant of Alteplase (tPA) designed to optimize these goals. **Why Tenecteplase is correct:** Tenecteplase has three key modifications that make it superior for bolus administration: 1. **Longer Half-life:** It has a significantly longer half-life (~20–24 minutes) compared to Alteplase, allowing it to be administered as a **single weight-based IV bolus over 5–10 seconds**. 2. **Higher Fibrin Specificity:** It is more specific to fibrin-bound plasminogen, reducing the risk of systemic fibrinogen depletion. 3. **PAI-1 Resistance:** It is highly resistant to inhibition by Plasminogen Activator Inhibitor-1 (PAI-1). **Why other options are incorrect:** * **Tissue plasminogen activator (Alteplase):** It has a very short half-life (4–6 minutes) and requires a complex administration protocol involving an initial bolus followed by a 90-minute continuous infusion. * **Reteplase:** While it has a longer half-life than Alteplase, it is administered as **two fixed-dose IV boluses** (10 units each) given 30 minutes apart, not as a single bolus. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice:** Tenecteplase is currently the preferred fibrinolytic for ST-Elevation Myocardial Infarction (STEMI) in the pre-hospital setting due to its ease of administration. * **Mechanism:** All these agents act by converting plasminogen to plasmin, which then degrades fibrin clots. * **Antidote:** In cases of life-threatening bleeding due to fibrinolytics, **Epsilon-aminocaproic acid** or **Tranexamic acid** can be used as inhibitors.

Q: Which of the following anticoagulants does not require routine laboratory coagulant profile monitoring?

Dabigatran. The correct answer is **Dabigatran**.Why Dabigatran is correct:Dabigatran is a **Direct Thrombin Inhibitor (DTI)** administered orally. Unlike traditional anticoagulants, it has a predictable pharmacokinetic and pharmacodynamic profile with a wide therapeutic window [3]. Therefore, it does not require routine laboratory monitoring (like PT/INR or aPTT) in most clinical scenarios [3]. This is a major advantage of **NOACs (Novel Oral Anticoagulants)**, which also include Factor Xa inhibitors like Rivaroxaban and Apixaban [1].Why the other options are incorrect:* **Warfarin:** This vitamin K antagonist has a narrow therapeutic index and significant inter-individual variability. It requires frequent monitoring of the **Prothrombin Time (PT)**, reported as the **International Normalized Ratio (INR)**, to prevent bleeding or thrombosis.* **Heparin (Unfractionated):** Due to its unpredictable binding to plasma proteins, UFH requires close monitoring using the **activated Partial Thromboplastin Time (aPTT)** to maintain a therapeutic range (usually 1.5–2.5 times the control) [4].* **Argatroban:** Although it is a DTI like Dabigatran, it is administered intravenously (usually for Heparin-Induced Thrombocytopenia) and requires **aPTT monitoring** to ensure safe dosing [2].**High-Yield NEET-PG Pearls:**1. **Antidote for Dabigatran:** Idarucizumab (a humanized monoclonal antibody fragment).2. **Monitoring if needed:** If emergency monitoring for Dabigatran is required, **Ecarin Clotting Time (ECT)** or Dilute Thrombin Time (dTT) are the most sensitive tests, as aPTT is not linear.3. **LMWH (Enoxaparin):** Also generally does not require monitoring, but if needed (e.g., in pregnancy or renal failure), **Anti-Factor Xa levels** are measured [5].

Q: Which drug is contraindicated in hemophilia?

Aspirin. **Explanation:** **Aspirin (Correct Answer):** Hemophilia is a genetic bleeding disorder characterized by a deficiency of clotting factors (Factor VIII in Hemophilia A; Factor IX in Hemophilia B), which impairs the **secondary hemostasis** (fibrin clot formation). Aspirin is a non-selective COX inhibitor that irreversibly inhibits platelet aggregation by blocking Thromboxane A2 (TXA2) synthesis. This impairs **primary hemostasis**. In a hemophilic patient, whose secondary hemostasis is already compromised, the addition of an antiplatelet agent like Aspirin can lead to catastrophic, life-threatening hemorrhage. Therefore, it is strictly contraindicated. **Incorrect Options:** * **Penicillin:** This is a beta-lactam antibiotic. While high doses of certain penicillins (like Carbenicillin) can occasionally interfere with platelet function, standard Penicillin G or V does not pose a specific contraindication in hemophilia. * **Aminocaproic acid:** This is an antifibrinolytic agent. It is actually used **therapeutically** in hemophilia (especially during dental extractions) to stabilize clots by inhibiting plasminogen activation. * **Diphenylhydantoin (Phenytoin):** This is an antiepileptic drug. While it has many side effects (gingival hyperplasia, hirsutism), it does not directly interfere with the coagulation cascade or platelet aggregation in a way that contraindicates its use in hemophilia. **High-Yield Clinical Pearls for NEET-PG:** * **Safe Analgesic:** **Paracetamol (Acetaminophen)** is the drug of choice for pain relief in hemophilic patients as it does not affect platelet function. * **Avoid IM Injections:** Intramuscular injections should be avoided in hemophiliacs to prevent hematoma formation; subcutaneous or intravenous routes are preferred. * **Desmopressin (DDAVP):** Used in Mild Hemophilia A to release stored Factor VIII and von Willebrand factor from endothelial Weibel-Palade bodies.

Q: Bone marrow aplasia is seen with all of the following drugs except:

Methicillin. **Explanation:** The question asks to identify the drug that does **not** typically cause bone marrow aplasia (aplastic anemia). **1. Why Methicillin is the Correct Answer:** Methicillin, a penicillinase-resistant penicillin, is classically associated with **Interstitial Nephritis** (a type IV hypersensitivity reaction), not bone marrow suppression. While it can rarely cause neutropenia, it is not a recognized cause of generalized bone marrow aplasia. Therefore, it is the "except" in this list. **2. Analysis of Incorrect Options (Drugs that cause Aplasia):** * **Chloramphenicol:** This is the most notorious drug associated with bone marrow toxicity. It causes two types: a dose-dependent, reversible suppression and a dose-independent, **idiosyncratic irreversible aplastic anemia** (often fatal). * **Alpha methyl hydantoin (Mephenytoin):** Hydantoin derivatives used in epilepsy are well-documented triggers for idiosyncratic bone marrow failure. * **Phenylbutazone:** An older NSAID that is now rarely used due to its high risk of causing severe, often fatal, aplastic anemia and agranulocytosis. **3. NEET-PG High-Yield Pearls:** * **Gold Standard for Aplastic Anemia:** Other high-yield drugs to remember include **Gold salts, Penicillamine, Carbamazepine, and Sulfa drugs.** * **Methicillin Side Effect:** Always associate Methicillin with **Acute Interstitial Nephritis (AIN)**—look for symptoms like fever, rash, and eosinophiluria in clinical vignettes. * **Chloramphenicol:** Remember the "Gray Baby Syndrome" (due to deficient glucuronidation) and its mechanism of inhibiting the 50S ribosomal subunit. * **Agranulocytosis vs. Aplasia:** While aplasia affects all three cell lines (pancytopenia), **Clozapine and Antithyroid drugs (PTU/Methimazole)** are more specifically associated with isolated agranulocytosis.

Question 1

Desferrioxamine is a drug used for:

Accepted Answer

Thalassemia

Answer

Kala-azar

Answer

Pernicious anaemia

Answer

Pain control

Question 2

Heparin is the commonly used anticoagulant in cardiac surgery. Which of the following statements about heparin is FALSE?

Accepted Answer

It is the weakest acid found in living beings.

Answer

Most commercial preparations of heparin are derived from pig intestine.

Answer

It acts by antithrombin activation.

Answer

It can produce thrombocytopenia.

Question 3

A 90-year-old woman with a fractured neck of femur is receiving low-molecular-weight heparin (LMWH). Which of the following statements regarding LMWH is true?

Accepted Answer

Its anticoagulant effect is by binding to antithrombin III.

Answer

It has molecular weight below 4000 daltons.

Answer

It should be administered two to three times a day.

Answer

It has lower bioavailability than standard heparin.

Question 4

Megaloblastic anemia is caused by all of the following EXCEPT:

Accepted Answer

Aspirin

Answer

Primidone

Answer

Methotrexate

Answer

Nitrous oxide

Question 5

Which of the following is a recombinant form of GM-CSF?

Accepted Answer

Sargramostim

Answer

Filgrastim

Answer

Aldesleukin

Answer

Interleukin-11

Question 6

What are the common side effects of erythropoietin?

Accepted Answer

Hypertension

Answer

Increased ferritin

Answer

Thrombocytosis

Answer

Decreased phosphate

Question 7

Which of the following fibrinolytic agents can be given as a single weight-based intravenous bolus over 10 seconds?

Accepted Answer

Tenecteplase (TNK)

Answer

Tissue plasminogen activator (tPA)

Answer

Reteplase (rPA)

Answer

Any of the above

Question 8

Which of the following anticoagulants does not require routine laboratory coagulant profile monitoring?

Accepted Answer

Dabigatran

Answer

Warfarin

Answer

Argatroban

Answer

Heparin

Question 9

Which drug is contraindicated in hemophilia?

Accepted Answer

Aspirin

Answer

Penicillin

Answer

Aminocaproic acid

Answer

Diphenylhydantoin

Question 10

Bone marrow aplasia is seen with all of the following drugs except:

Accepted Answer

Methicillin

Answer

Chloramphenicol

Answer

Alpha methyl hydantoin

Answer

Phenylbutazone

Drugs Affecting Blood and Blood Formation — MCQs

Drugs Affecting Blood and Blood Formation — MCQs

On this page

Practice by Chapter

Want unlimited practice?